Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Wolff

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
BMJ Open|May 8, 2024
Risk and time preferences in individuals with lifestyle-related and non-lifestyle-related cardiovascular diseases: a pilot studyNadja Kairies-Schwarz, Irene Mussio, Natalia Bulla-Holthaus, et al.
Acta Cardiologica|February 15, 2020
Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trialsMaximilian Brockmeyer, Yingfeng Lin, Claudio Parco, et al.
Circulation. Heart Failure|September 9, 2024
Endovascular Treatment of Flow-Limiting Iliofemoral Stenosis Improves Left Ventricular Diastolic Function in Patients With HFpEF by Reducing Aortic Pulsatile LoadSven Baasen, Manuel Stern, Patricia Wischmann, et al.
International Journal of Cardiology|June 11, 2023
Risk-adjusted management in catheterization procedures for non-ST-segment elevation myocardial infarction: A standard operating procedure pilot studyClaudio Parco, Jennifer Tröstler, Maximilian Brockmeyer, et al.
ESC Heart Failure|November 7, 2022
Meta-analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomesGeorg Wolff, Yingfeng Lin, Cihan Akbulut, et al.
Diabetes, Obesity & Metabolism|March 1, 2024
Assessing the potential for precision medicine in body weight reduction with regard to type 2 diabetes mellitus therapies: A meta-regression analysis of 120 randomized controlled trialsKris G Vargas, Tobias Rütten, Benedikt Siemes, et al.
Critical Care (London, England)|October 26, 2022
Virtual and augmented reality in critical care medicine: the patient's, clinician's, and researcher's perspectiveRaphael Romano Bruno, Georg Wolff, Bernhard Wernly, et al.
The Canadian Journal of Cardiology|September 23, 2019
Routine Glycoprotein IIb/IIIa Inhibitor Therapy in ST-Segment Elevation Myocardial Infarction: A Meta-analysisAthanasios Karathanos, Yingfeng Lin, Lisa Dannenberg, et al.
Acta Cardiologica|April 16, 2019
Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding riskMaximilian Brockmeyer, Georg Wolff, Torben Krieger, et al.
International Journal of Cardiology|September 22, 2018
Safety and efficacy of Tirofiban in STEMI-patientsLisa Dannenberg, Georg Wolff, David Naguib, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
BMJ Open|May 8, 2024
Risk and time preferences in individuals with lifestyle-related and non-lifestyle-related cardiovascular diseases: a pilot studyNadja Kairies-Schwarz, Irene Mussio, Natalia Bulla-Holthaus, et al.
Acta Cardiologica|February 15, 2020
Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trialsMaximilian Brockmeyer, Yingfeng Lin, Claudio Parco, et al.
Circulation. Heart Failure|September 9, 2024
Endovascular Treatment of Flow-Limiting Iliofemoral Stenosis Improves Left Ventricular Diastolic Function in Patients With HFpEF by Reducing Aortic Pulsatile LoadSven Baasen, Manuel Stern, Patricia Wischmann, et al.
International Journal of Cardiology|June 11, 2023
Risk-adjusted management in catheterization procedures for non-ST-segment elevation myocardial infarction: A standard operating procedure pilot studyClaudio Parco, Jennifer Tröstler, Maximilian Brockmeyer, et al.
ESC Heart Failure|November 7, 2022
Meta-analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomesGeorg Wolff, Yingfeng Lin, Cihan Akbulut, et al.
Diabetes, Obesity & Metabolism|March 1, 2024
Assessing the potential for precision medicine in body weight reduction with regard to type 2 diabetes mellitus therapies: A meta-regression analysis of 120 randomized controlled trialsKris G Vargas, Tobias Rütten, Benedikt Siemes, et al.
Critical Care (London, England)|October 26, 2022
Virtual and augmented reality in critical care medicine: the patient's, clinician's, and researcher's perspectiveRaphael Romano Bruno, Georg Wolff, Bernhard Wernly, et al.
The Canadian Journal of Cardiology|September 23, 2019
Routine Glycoprotein IIb/IIIa Inhibitor Therapy in ST-Segment Elevation Myocardial Infarction: A Meta-analysisAthanasios Karathanos, Yingfeng Lin, Lisa Dannenberg, et al.
Acta Cardiologica|April 16, 2019
Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding riskMaximilian Brockmeyer, Georg Wolff, Torben Krieger, et al.
International Journal of Cardiology|September 22, 2018
Safety and efficacy of Tirofiban in STEMI-patientsLisa Dannenberg, Georg Wolff, David Naguib, et al.
Pageof 11